Akebia Therapeutics
(AKBA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 147,449 | 104,644 | 70,156 | 187,335 | 49,778 |
| Marketable Securities | N/A | N/A | 247,636 | 73,008 | 88,676 |
| Receivables | 39,109 | 233,662 | 34,216 | 33,823 | N/A |
| Inventories | 116,349 | 114,245 | N/A | N/A | N/A |
| TOTAL | $309,533 | $468,275 | $358,356 | $296,321 | $141,017 |
| Non-Current Assets | |||||
| PPE Net | 10,380 | 8,023 | 3,617 | 2,612 | 540 |
| Intangibles | 346,265 | 383,206 | 0 | 0 | 0 |
| Other Non-Current Assets | 105,023 | 137,036 | 2,274 | 1,283 | 1,383 |
| TOTAL | $461,668 | $528,265 | $5,891 | $3,895 | $1,923 |
| Total Assets | $771,201 | $996,540 | $364,247 | $300,216 | $142,940 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 15,000 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 39,217 | 42,796 | 6,998 | 2,039 | 2,313 |
| Accrued Expenses | 129,071 | 150,917 | 52,441 | 30,261 | 9,555 |
| TOTAL | $208,118 | $265,693 | $141,106 | $114,268 | $11,868 |
| Non-Current Liabilities | |||||
| Long Term Debt | 75,805 | N/A | N/A | N/A | N/A |
| Deferred Revenues | 39,830 | 56,980 | 81,667 | 81,968 | N/A |
| Other Non-Current Liabilities | 59,401 | 29,573 | 22 | 27 | 5 |
| TOTAL | $168,326 | $94,919 | $100,567 | $117,828 | $74 |
| Total Liabilities | $376,444 | $360,612 | $241,673 | $232,096 | $11,942 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 129,858 | 117,122 | 48,346 | 38,830 | 37,943 |
| Common Shares | 1 | 1 | N/A | N/A | N/A |
| Retained earnings | -794,054 | -514,395 | -370,807 | -297,136 | -161,389 |
| Other shareholders' equity | 0 | -261 | -442 | -42 | -396 |
| TOTAL | $394,757 | $635,928 | $122,574 | $68,120 | $130,998 |
| Total Liabilities And Equity | $771,201 | $996,540 | $364,247 | $300,216 | $142,940 |